TY - JOUR
T1 - PGE2 reverses AVP inhibition of HCO3- absorption in rat MTAL by activation of protein kinase C
AU - Good, David W.
PY - 1996
Y1 - 1996
N2 - In the medullary thick ascending limb (MTAL) of the rat, prostaglandin E2 (PGE2) reverses inhibition of HCO3- absorption (JHCO3) by arginine vasopressin (AVP) by inhibiting AVP-stimulated adenosine 3′, 5′-cyclic monophosphate (cAMP) production. To determine whether this regulation by PGE2 involves protein kinase C (PKC), MTAL segments were perfused in vitro with physiological solutions containing 25 mM HCO3- (pH 7.4). With 10-10 M AVP in the bath, addition of 10-6 M PGE2 to the bath increased JHCO3 from 7.8 ± 0.4 to 13.0 ± 1.1 pmol·min-1·mm-1 (P < 0.01). This effect was blocked completely by pretreatment with the PKC inhibitors staurosporine or chelerythrine chloride (10-7 M in the bath). With both AVP and PGE2 in the bath, addition of staurosporine or chelerythrine to the bath decreased JHCO3 from 12.2 ± 1.1 to 7.3 ± 0.6 pmol·min-1·mm-1 (P < 0.005). Neither staurosporine nor chelerythrine affected JHCO3 under basal conditions or in the presence of AVP alone. With AVP in the bath, addition of phorbol 12-myristate 13-acetate (PMA, 10-6 M) to the bath increased JHCO3 from 5.0 ± 0.5 to 9.1 ± 1.0 pmol·min-1·mm-1 (P < 0.01). Similar to PGE2, PMA had no effect on JHCO3 in the absence of AVP or in the presence of 10-6 M bath forskolin. The effect of PMA to stimulate JHCO3 in the presence of AVP was abolished by pretreatment with pertussis toxin (2 × 10-11 M). We conclude that 1) PGE2 reverses AVP inhibition of HCO3- absorption by activation of PKC, 2) PKC likely increases JHCO3 by inhibiting AVP-stimulated cAMP production via a Gi-dependent mechanism, and 3) PKC activity has no influence on basal HCO3- absorption rate. adenosine 3′, 5′-cyclic monophosphate; signal transduction; phorbol ester;.
AB - In the medullary thick ascending limb (MTAL) of the rat, prostaglandin E2 (PGE2) reverses inhibition of HCO3- absorption (JHCO3) by arginine vasopressin (AVP) by inhibiting AVP-stimulated adenosine 3′, 5′-cyclic monophosphate (cAMP) production. To determine whether this regulation by PGE2 involves protein kinase C (PKC), MTAL segments were perfused in vitro with physiological solutions containing 25 mM HCO3- (pH 7.4). With 10-10 M AVP in the bath, addition of 10-6 M PGE2 to the bath increased JHCO3 from 7.8 ± 0.4 to 13.0 ± 1.1 pmol·min-1·mm-1 (P < 0.01). This effect was blocked completely by pretreatment with the PKC inhibitors staurosporine or chelerythrine chloride (10-7 M in the bath). With both AVP and PGE2 in the bath, addition of staurosporine or chelerythrine to the bath decreased JHCO3 from 12.2 ± 1.1 to 7.3 ± 0.6 pmol·min-1·mm-1 (P < 0.005). Neither staurosporine nor chelerythrine affected JHCO3 under basal conditions or in the presence of AVP alone. With AVP in the bath, addition of phorbol 12-myristate 13-acetate (PMA, 10-6 M) to the bath increased JHCO3 from 5.0 ± 0.5 to 9.1 ± 1.0 pmol·min-1·mm-1 (P < 0.01). Similar to PGE2, PMA had no effect on JHCO3 in the absence of AVP or in the presence of 10-6 M bath forskolin. The effect of PMA to stimulate JHCO3 in the presence of AVP was abolished by pretreatment with pertussis toxin (2 × 10-11 M). We conclude that 1) PGE2 reverses AVP inhibition of HCO3- absorption by activation of PKC, 2) PKC likely increases JHCO3 by inhibiting AVP-stimulated cAMP production via a Gi-dependent mechanism, and 3) PKC activity has no influence on basal HCO3- absorption rate. adenosine 3′, 5′-cyclic monophosphate; signal transduction; phorbol ester;.
KW - Inhibitory g protein
KW - Prostaglandin e receptor
UR - http://www.scopus.com/inward/record.url?scp=0030163726&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030163726&partnerID=8YFLogxK
U2 - 10.1152/ajprenal.1996.270.6.f978
DO - 10.1152/ajprenal.1996.270.6.f978
M3 - Article
C2 - 8764317
AN - SCOPUS:0030163726
SN - 0002-9513
VL - 270
SP - F978-F985
JO - American Journal of Physiology
JF - American Journal of Physiology
IS - 6 PART 2
ER -